Novanta Photonics (NOVT) - Long-Term Debt to Capital Coefficient

Corporate emblem and logo of Novanta Inc. (NOVT)

Novanta Inc. (NOVT) develops precision automation and lasers, whose integration into diagnostic equipment ensures a stable cash flow and high profitability. Business growth relies on the development of robotics and strong relationships with global vendors. The share price retrospective on GURU.Markets reflects the asset's dynamics, where the indicator is 0.14. Patent protection of unique sensors effectively blocks new players from entering the market.

NOVT Novanta Inc: Long-Term Debt to Equity in the range 07/04/2022 - 10/30/2026
Core merchandise of Novanta Photonics

Investors use this ratio to assess financial stability and the degree of business reliance on borrowed funds for long-term planning. The long-term debt-to-equity ratio, currently 0.14, determines the ability of Novanta Inc. to finance the development of high-precision medical lasers and robotics, which is clearly evidenced by the trend of the long-term liabilities-to-equity ratio.

Competing companies

DXCM (DexCom Inc) - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital PEN|HAE (Haemonetics Company) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital INSP (Inspire Medical Systems)|procept-biorobotics.com (PRCT) - Long-Term Liabilities to Capital|CNMD - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient PLSE (Pulse Biosciences Inc)|INMD: Long-Term Debt to Capital|Picard Group (PMI) - Long-Term Debt to Capital|Long-Term Debt to Equity Surmodics, Inc.|Senseonics Corp - Long-Term Liabilities to Equity|Long-Term Debt to Capital NPCE|TCMD - Long-Term Liabilities to Capital|SANUWAVE Health, Inc. - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Outset Medical Corp OM|ELMD: Long-Term Debt to Equity Ratio|lensar.com - Long-Term Loans to Capital Ratio|RCEL: Long-Term Debt to Capital|PROF - Ratio of Long-Term Indebtedness to Capital|BDMD (Baird Medical Investment Holdings) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio EDAP Medical (EDAP)|Long-Term Debt to Equity Ratio APYX (Apyx Medical)|ICCM (icecure-medical.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Pulmonx LUNG|TELA - Long-Term Debt to Equity Ratio|CytoSorbents Corp. - Long-Term Debt to Capital|Long-Term Liabilities to Capital Sensus|ZYXI: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio ECOR|RBOT (Vicarious Surgical Inc) - Long-Term Debt to Capital|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital ICU|Long-Term Debt to Equity Ratio iridex.com IRIX|Long-Term Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Long-Term Debt to Capital Beyond Air Inc XAIR|PFSA - Long-Term Debt to Equity|SSKN: Long-Term Debt to Equity|GCTK (GlucoTrack) - Long-Term Debt to Equity Ratio|NanoVibronix Inc. - Long-Term Debt to Capital Coefficient|VERO (Venus Concept Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital nuwellis.com NUWE|Long-Term Debt to Equity Aethlon Medical, Inc. (AEMD)|asensus.com (ASXC) - Long-Term Indebtedness to Equity|Avinger, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital BioSig Technologies Inc. BSGM|Cutera, Inc. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital knowlabs.co KNW|Inari Medical (NARI) - Long-Term Debt to Equity|Long-Term Liabilities to Equity NVRO (Nevro Corp)|Long-Term Debt to Equity ReShape Lifesciences, Inc.|Long-Term Debt to Equity Ratio Silk Road Medical Inc (SILK)